Buckle up! The Curiosity Cube, our mobile science lab, is back. See the Cube come to life as we prepare to bring hands-on science to a community near you! #SPARKCuriosity
MilliporeSigma
生物技术研究
Burlington，MA 214,600 位关注者
Together, we impact life and health with science.
关于我们
Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come. The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries. Intended only for US/CA visitors.
- 网站
-
https://www.sigmaaldrich.com
MilliporeSigma的外部链接
- 所属行业
- 生物技术研究
- 规模
- 超过 10,001 人
- 总部
- Burlington，MA
- 类型
- 上市公司
- 创立
- 1668
- 领域
- Life Science Research、Drug Discovery & Development、Lab Filtration、Lab Water、Bioscience、Upstream & Downstream Bioprocessing、BioMonitoring、Lab Solutions、Life Sciences和Process Solutions
地点
-
主要
获取路线
400 Summit Drive
US，MA，Burlington，01803
MilliporeSigma员工
动态
-
We’re excited to unveil our cutting-edge formulation and technology center in Navi Mumbai, India, serving as the innovation hub for the Asia Pacific region. Our hub provides technical expertise to healthcare solution providers aiming to develop high-quality generics using our advanced technology and excipients. Watch how we are driving pharma innovation and bringing therapy to patients.
-
Our Amicon Ultra Centrifugal filters are ready for a spin ?? Let's unbox them! Learn more: https://ms.spr.ly/6043qkFsV
-
What if we could make antibody-drug conjugates (ADCs) faster and safer? These powerful medicines target cancer cells while sparing healthy ones. Joe Cianciolo breaks down how the new Mobius ADC Reactor is revolutionizing ADC production by overcoming a major hurdle the industry previously faced.
-
Hooray for Pi Day! It's time to celebrate the sweetest constant around ?? #PiDay Find out how you can get a Pi Day t-shirt here: https://ms.spr.ly/6040qROca
-
-
Construction of our new Bioprocessing Center in Daejeon, South Korea is well underway to meet the growing demand for monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and more in the Asia-Pacific region. Set to open in 2026, this 44,500 m2 facility will enhance supply resilience and robustness across the region and beyond. Stay tuned for updates and check out our progress here: https://ms.spr.ly/6049qzhQc
-
Patients can't wait—and neither can we! We started by targeting cancer cells with precision, but that’s just the beginning. The potential of antibody-drug conjugates (ADCs) is vast—imagine tackling everything from muscular dystrophy to other complex diseases. Watch as Sowmyan S., Lisa McDermott, and Yomadis Ortiz share the exciting possibilities ahead.
-
What if we could improve drug screening so that patients receive the medicine they need sooner? Using technology like this organoid swelling assay featured in the video, scientists are leveraging advanced cellular models to shape the future of medicine. This innovative form of 3D cell culture shortens the time it takes to assess a drug’s interaction with the human body—helping deliver essential therapies more quickly.
-
It's mission possible with Amie Muir! Tag along as one of our molecular biologists at our Glasgow testing facility takes on a new mission: testing medicine for viral contaminants to ensure they are safe.
-
Supporting future scientists starts with opportunities to explore STEM. That’s why we’re proud to partner with Girlstart, a women-led organization inspiring girls in STEM. This International Women’s Day, we’re reflecting on our shared commitment to expanding hands-on programs like Girlstart After School, Summer Camp, and Community STEM initiatives which reach 20,000 girls and families each year. #SPARKCuriosity #IWD2025
-